The Patent Finder

The J. David Gladstone Institutes

42 patents currently held · Updated Nov 22, 2026
18 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 9 name spellings.

11
Ending by 2030
Nov 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 26, 2026
    The maintenance fee for Methods and compositions for modulating tau levels (US 9,040,521) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
  • 3 fees due Jan 16 to 21, 2027 · next Jan 16
  • 2 fees due Feb 11, 2027
  • 2 fees due Apr 3 to 22, 2027 · next Apr 3
  • 3 fees due May 7 to 19, 2027 · next May 7
  • 1 fee due Jun 1, 2027
    The maintenance fee for Agents that reduce neuronal overexcitation (US 9,198,982) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
  • 1 fee due Aug 2, 2027
    The maintenance fee for Methods of Generating Neural Stem Cells (US 9,249,391) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,347,085Methods and compositions for reducing amyloid beta levels
In force
 · USPTO record
In forceUSPTO record
US 7,771,967Nucleic acid encoding apolipoprotein E-I3
In force
 · USPTO record
In forceUSPTO record
US 7,951,367Methods and compositions for reducing amyloid beta levels
In force
 · USPTO record
In forceUSPTO record
US 8,388,953Method of increasing cathepsin B-induced cleavage of amyloid-β peptides
In force
 · USPTO record
In forceUSPTO record
US 9,084,813Agents that reduce neuronal overexcitation
In force
 · USPTO record
In forceUSPTO record
US 8,580,492Screening method for the identification of inhibitors of HIV Tat methylation by the lysine methyltransferase Set7/9
In force
 · USPTO record
In forceUSPTO record
US 9,198,982Agents that reduce neuronal overexcitation
In force
 · USPTO record
In forceUSPTO record
US 8,034,350Methylated tat polypeptides and methods of use thereof
In force
 · USPTO record
In forceUSPTO record
US 9,585,907Methods and compositions for modulating Tau levels
In force
 · USPTO record
In forceUSPTO record
US 8,815,589Methods of Generating Neural Stem Cells
In force
 · Medium confidence
In forceMedium confidence
10 of 42 patents shown.
Pro members see all 42.
Pro members: see all 42 patents
Also on record, not counted in the 42: 18 patents in force now held by others · 40 lapsed for an unpaid fee · 28 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 8 abandoned · 16 no status recorded

Rows 11 to 27 of 27 are for members. The first 10 are on the company page.
Pro members see all 27 published applications.
Upgrade to Pro
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited